about
Identification of Tazarotenic Acid as the First Xenobiotic Substrate of Human Retinoic Acid Hydroxylase CYP26A1 and CYP26B1Tazarotene: therapeutic strategies in the treatment of psoriasis, acne and photoaging.Pharmacotherapy of acne.Efficacy and safety of topical tazarotene: a review.Treating Psoriasis During Pregnancy: Safety and Efficacy of Treatments.Psoriasis in those planning a family, pregnant or breast-feeding. The Australasian Psoriasis Collaboration.Seborrheic keratoses: a study comparing the standard cryosurgery with topical calcipotriene, topical tazarotene, and topical imiquimod.Psoriasis in pregnancy: challenges and solutions.
P2860
Q28115020-2DD6569A-6A31-4ADA-9CA7-C88A315968AFQ35747090-CB64BE0B-5C0E-4B86-BC8E-4D58C33FC83FQ37123406-17ECD595-780F-4D4D-B97E-1F1BB188BB1DQ37705240-F0AB9503-465A-49B9-8235-D37FA64F4FE5Q38543325-C0ADCB03-57BB-483E-934A-F3B74D38DA8FQ38764476-F41831E5-20FC-416E-BB5D-F058192872A5Q44847888-5BBF1A80-0834-4921-BA25-E8F8E7BF3C1EQ55553649-3A9838C7-3212-48EC-A6D4-77AD923566D6
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Pharmacokinetics and safety of tazarotene.
@ast
Pharmacokinetics and safety of tazarotene.
@en
type
label
Pharmacokinetics and safety of tazarotene.
@ast
Pharmacokinetics and safety of tazarotene.
@en
prefLabel
Pharmacokinetics and safety of tazarotene.
@ast
Pharmacokinetics and safety of tazarotene.
@en
P356
P1476
Pharmacokinetics and safety of tazarotene.
@en
P2093
P356
10.1067/MJD.2000.108321
P407
P433
P577
2000-08-01T00:00:00Z